Solarvest BioEnergy Inc. Closes Non-Brokered Private Placement

SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest" or the "Company"),
wishes to announce it has arranged a non-brokered private placement, pursuant to
which the investors will purchase from the Company up to 300,000 common shares
priced at $0.25 per share for gross proceeds of $75,000. Proceeds from this
private placement will be used as general working capital.


This placement will be entirely subscribed by a director and officer who is also
a Control Person of the Company and the placement is exempt from shareholder
approval accordance with MI 61-101 (Protection of Minority Security Holders in
Special Transactions).


The shares will be subject to resale restrictions for a period of four months
from the closing date under applicable securities legislation. Completion of the
private placement will be subject to a number of conditions including the
approval of the TSX Venture Exchange. 


About Solarvest: Solarvest is committed to the development of sustainable and
renewable energy sources to meet growing energy demands and environmental
challenges. Solarvest's intellectual property is a biologically-based hydrogen
producing technology, which provides a method for controlling key genes in algae
resulting in the continuous production of hydrogen gas. Solarvest's bio-energy
production system utilizes light and carbon dioxide to produce hydrogen leaving
a clean positive environmental footprint.


The statements made in this news release may contain forward-looking statements
that may involve a number of risks and uncertainties. Actual events or results
could differ materially from the Company's expectations and projections.